Compare Home Depot Inc (HD) vs Hinge Health Inc. Class A Common Stock (HNGE) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Home Depot Inc vs Hinge Health Inc. Class A Common Stock — how do they compare? Home Depot Inc trades at $298 (market cap $293.24B), while Hinge Health Inc. Class A Common Stock trades at $104.95 (market cap $8.48B). The key difference: Home Depot Inc is far larger — about 34.6× Hinge Health Inc. Class A Common Stock's market cap, and Home Depot Inc pays a 3.17% dividend while Hinge Health Inc. Class A Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Home Depot Inc for 139 Days and Hinge Health Inc. Class A Common Stock for 0 Days on average.
| HD | HNGE | |
|---|---|---|
Market Cap | $293.24B | $8.48B |
Volume | 4,521,013 | 879,799 |
Sector | Consumer Cyclical | Health |
52-Week High | $391.90 | $105.14 |
52-Week Low | $281.15 | $31.17 |
Typical Hold Time | 139 Days | 0 Days |
Enterprise Value | $353.72B | $8.10B |
Dividend Yield | 3.17% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Home Depot (HD) trades at $295.51, up 1.68% with strong earnings momentum after beating Q2 2026 EPS estimates. The stock shows bearish technical signals but maintains solid fundamentals with $159.51B revenue and 8.41% net margin. Recent institutional activity shows mixed positioning while analyst consensus remains bullish with a $379.93 price target.
HD offers value with reasonable valuation multiples (P/E 20.57) and consistent profitability, though margin compression and housing market sensitivity pose risks. The 58.73% buy rating from analysts suggests upside potential, but investors should monitor Pro segment performance amid weakening big-ticket demand.
Hinge Health (HNGE) trades at $105.14, up 0.31% on the day and near its 52-week high. The stock shows strong analyst support with a 93.75% buy rating, though the current price exceeds the consensus target of $101.62. Recent earnings beat expectations in two of the last three quarters, with Q3 2026 results due November 2. Fundamentals indicate robust revenue growth projections from $588 million in 2025 to $720 million in 2026, alongside a shift to profitability, but valuation multiples like EV/EBITDA at 82.33 remain elevated.
The outlook is cautiously optimistic given projected profitability and expansion into migraine and GI care, but risks include high insider selling, competitive pressures, and the stock's premium valuation. Execution on growth targets and Q3 earnings will be critical for sustaining momentum.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Home Depot Inc
Home Depot is the world's largest home improvement specialty retailer, operating more than 2,300 warehouse-format stores offering more than 30,000 products in store and 1 million products online in the United States, Canada, and Mexico. Its stores offer numerous building materials, home improvement products, lawn and garden products, and decor products and provide various services, including home improvement installation services and tool and equipment rentals. The acquisition of distributor Interline Brands in 2015 allowed Home Depot to enter the maintenance, repair, and operations business, which has been expanded through the tie-up with HD Supply (2020). The addition of the Company Store brought textile exposure to Home Depot's lineup.
Read more on HD →About Hinge Health Inc. Class A Common Stock
Hinge Health Inc. operates a digital musculoskeletal (MSK) care platform that delivers exercise therapy for joint and muscle conditions through health plans and employers. Its Precision Motion Technology combines wearable sensors and computer vision to guide patients through clinician-directed physical therapy remotely.
Read more on HNGE →
